Analysis of Transcriptome Alterations in Parkinson’s Disease

The information that stems from the primary structure of DNA lies within the basis of every sign formation, although the regulation of any process occurs in different levels of cellular processes including transcription. In this context analysis of gene transcription is of great importance to improve our understanding of the pathogenesis of diverse disorders, and Parkinson’s disease (PD) is not an exception. However, each disease has its own unique etiopathogenesis within organs and tissues, which is caused by disease-specific processes in cells, as well as at the genetic level. Knowledge of the etiology and pathogenesis of diseases at a cellular level opens wide prospects for diagnosis and treatment, even for complex and incurable disorders such as PD. Therefore, it is necessary to study the pathogenesis of specific disease at the cellular and genetic levels. Accordingly, the expression profiles of large numbers of genes are being studied in different neurodegenerative disorders, including PD. Although the mechanisms that initiate neuronal pathology in sporadic PD remain largely obscure, in this chapter we have tried to summarize all current knowledge in the field of the PD transcriptomics.

[1]  E. Sinforiani,et al.  Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease , 2011, Neurobiology of Aging.

[2]  S. Illarioshkin,et al.  [Expression of GSK3B gene in peripheral blood in patient with Parkinson's disease]. , 2011, Molekuliarnaia biologiia.

[3]  C. Zechner,et al.  Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. , 2010, Cell metabolism.

[4]  P. Riederer,et al.  Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson’s disease , 2010, Journal of Neural Transmission.

[5]  Manuel B. Graeber,et al.  PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease , 2010, Science Translational Medicine.

[6]  B. de Strooper,et al.  Dysregulated microRNAs in neurodegenerative disorders. , 2010, Seminars in cell & developmental biology.

[7]  Shoji Nakamura,et al.  Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease , 2010, Brain Research.

[8]  V. Álvarez,et al.  FGF20 rs12720208 SNP and microRNA-433 variation: No association with Parkinson's disease in Spanish patients , 2010, Neuroscience Letters.

[9]  Julie A Saugstad,et al.  MicroRNAs as Effectors of Brain Function with Roles in Ischemia and Injury, Neuroprotection, and Neurodegeneration , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  A. Gulino,et al.  MicroRNAs as biomarkers for CNS cancer and other disorders , 2010, Brain Research.

[11]  S. Limborska,et al.  Expression analysis of suppression of tumorigenicity 13 gene in patients with Parkinson's disease , 2010, Neuroscience Letters.

[12]  E. Eriksson,et al.  PITX3 polymorphism is associated with early onset Parkinson's disease , 2010, Neurobiology of Aging.

[13]  Epaminondas Doxakis,et al.  Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153 , 2010, The Journal of Biological Chemistry.

[14]  Ming Yi,et al.  Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease , 2010, PloS one.

[15]  Desmond J. Smith Mitochondrial dysfunction in mouse models of Parkinson’s disease revealed by transcriptomics and proteomics , 2009, Journal of bioenergetics and biomembranes.

[16]  S. Mandel,et al.  Modeling sporadic Parkinson's disease by silencing the ubiquitin E3 ligase component, SKP1A. , 2009, Parkinsonism & related disorders.

[17]  V. Scaria,et al.  MicroRNAs: novel therapeutic targets in neurodegenerative diseases. , 2009, Drug discovery today.

[18]  I. McKeith,et al.  Single‐cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene , 2009, Annals of neurology.

[19]  N. Arora,et al.  Interaction Map and Selection of microRNA Targets in Parkinson's Disease-Related Genes , 2009, Journal of biomedicine & biotechnology.

[20]  C. Barbato,et al.  Searching for MIND: MicroRNAs in Neurodegenerative Diseases , 2009, Journal of biomedicine & biotechnology.

[21]  J. Im,et al.  Repression of α-synuclein expression and toxicity by microRNA-7 , 2009, Proceedings of the National Academy of Sciences.

[22]  M. Horan Application of serial analysis of gene expression to the study of human genetic disease , 2009, Human Genetics.

[23]  F. Benes,et al.  Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. , 2009, Brain : a journal of neurology.

[24]  T. Illig,et al.  The transcription factor PITX3 is associated with sporadic Parkinson's disease , 2009, Neurobiology of Aging.

[25]  F. Mastaglia,et al.  Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? , 2009, Movement disorders : official journal of the Movement Disorder Society.

[26]  M. Wood,et al.  Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics. , 2009, Human molecular genetics.

[27]  Lan Jin,et al.  Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. , 2009, Nature structural & molecular biology.

[28]  M. Onofrj,et al.  Peripheral cytokines profile in Parkinson’s disease , 2009, Brain, Behavior, and Immunity.

[29]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[30]  C. Kruse,et al.  Analysis of Gene Expression in Parkinson's Disease: Possible Involvement of Neurotrophic Support and Axon Guidance in Dopaminergic Cell Death , 2009, Brain pathology.

[31]  Yi Wen Kong,et al.  How do microRNAs regulate gene expression? , 2008, Biochemical Society transactions.

[32]  Praveen Sethupathy,et al.  MicroRNA target site polymorphisms and human disease. , 2008, Trends in genetics : TIG.

[33]  Chunxu Qu,et al.  Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum , 2008, Neuroscience.

[34]  G. Schratt,et al.  MicroRNA function in neuronal development, plasticity and disease. , 2008, Biochimica et biophysica acta.

[35]  Alan Mackay-Sim,et al.  Fibroblast and Lymphoblast Gene Expression Profiles in Schizophrenia: Are Non-Neural Cells Informative? , 2008, PloS one.

[36]  S. Cohen,et al.  microRNAs in neurodegeneration , 2008, Current Opinion in Neurobiology.

[37]  Michael T. McManus,et al.  Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration , 2008, Proceedings of the National Academy of Sciences.

[38]  B. Hyman,et al.  Transcriptional dysregulation in a transgenic model of Parkinson disease , 2008, Neurobiology of Disease.

[39]  Gaofeng Wang,et al.  Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. , 2008, American journal of human genetics.

[40]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[41]  A. Schier,et al.  Members of the miRNA-200 Family Regulate Olfactory Neurogenesis , 2008, Neuron.

[42]  Richard D. Smith,et al.  Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease. , 2008, Journal of proteome research.

[43]  Peter T. Nelson,et al.  MicroRNAs (miRNAs) in Neurodegenerative Diseases , 2008, Brain pathology.

[44]  J. Steitz,et al.  Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.

[45]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[46]  G. Hannon,et al.  A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons , 2007, Science.

[47]  S. Hébert,et al.  miRNAs in Neurodegeneration , 2007, Science.

[48]  Richard J Jackson,et al.  MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation. , 2007, Genes & development.

[49]  P. Greengard,et al.  Cerebellar neurodegeneration in the absence of microRNAs , 2007, The Journal of experimental medicine.

[50]  J. Keller,et al.  RNA in Brain Disease: No Longer Just "The Messenger in the Middle" , 2007, Journal of neuropathology and experimental neurology.

[51]  P S Whitton,et al.  Inflammation as a causative factor in the aetiology of Parkinson's disease , 2007, British journal of pharmacology.

[52]  W. Filipowicz,et al.  Repression of protein synthesis by miRNAs: how many mechanisms? , 2007, Trends in cell biology.

[53]  Shu Zheng,et al.  What we know about ST13, a co-factor of heat shock protein, or a tumor suppressor? , 2007, Journal of Zhejiang University SCIENCE B.

[54]  J. Growdon,et al.  Molecular markers of early Parkinson's disease based on gene expression in blood , 2007, Proceedings of the National Academy of Sciences.

[55]  M. Farrer,et al.  The ups and downs of α‐synuclein mRNA expression , 2007 .

[56]  L. Moran,et al.  The medial and lateral substantia nigra in Parkinson’s disease: mRNA profiles associated with higher brain tissue vulnerability , 2007, Neurogenetics.

[57]  L. Moran,et al.  Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra , 2007, Acta Neuropathologica.

[58]  R. Levine,et al.  Staufen- and FMRP-Containing Neuronal RNPs Are Structurally and Functionally Related to Somatic P Bodies , 2006, Neuron.

[59]  B. Davidson,et al.  RNA polymerase III transcribes human microRNAs , 2006, Nature Structural &Molecular Biology.

[60]  Sonja W. Scholz,et al.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.

[61]  R. Plasterk,et al.  The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.

[62]  T. Klockgether,et al.  Transcriptional changes in multiple system atrophy and Parkinson's disease putamen , 2006, Experimental Neurology.

[63]  N. Rajewsky microRNA target predictions in animals , 2006, Nature Genetics.

[64]  L. Moran,et al.  Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson’s disease , 2006, Neurogenetics.

[65]  T. Kaysser-Kranich,et al.  Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease , 2006, Neurobiology of Disease.

[66]  Michael E. Greenberg,et al.  A brain-specific microRNA regulates dendritic spine development , 2006, Nature.

[67]  L. Moran,et al.  Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease , 2006, Neurogenetics.

[68]  Olga Varlamova,et al.  A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Mariza de Andrade,et al.  High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.

[70]  E. Bézard,et al.  Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease , 2005, Neurobiology of Disease.

[71]  F. Dietrich,et al.  Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra , 2005, Movement disorders : official journal of the Movement Disorder Society.

[72]  E. Tan,et al.  Functional COMT variant predicts response to high dose pyridoxine in Parkinson's disease , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[73]  F. Middleton,et al.  Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[74]  S. Mandel,et al.  Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70 , 2005, Annals of the New York Academy of Sciences.

[75]  Ling Lin,et al.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. , 2005, Human molecular genetics.

[76]  R. Jensen,et al.  Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. , 2005, Archives of neurology.

[77]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[78]  Lena Smirnova,et al.  Regulation of miRNA expression during neural cell specification , 2005, The European journal of neuroscience.

[79]  R. Russell,et al.  Principles of MicroRNA–Target Recognition , 2005, PLoS biology.

[80]  Axel T Brunger,et al.  Structure and function of SNARE and SNARE-interacting proteins , 2005, Quarterly Reviews of Biophysics.

[81]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[82]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[83]  Y. Suh,et al.  α‐Synuclein induces apoptosis by altered expression in human peripheral lymphocytes in Parkinson’s disease , 2004 .

[84]  S. Mandel,et al.  Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes , 2004, Journal of Neural Transmission.

[85]  Pasko Rakic,et al.  Microarray analysis of microRNA expression in the developing mammalian brain , 2004, Genome Biology.

[86]  Eden R Martin,et al.  Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. , 2004, American journal of human genetics.

[87]  Thomas Tuschl,et al.  Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. , 2004, RNA.

[88]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[89]  Konstantin Khrapko,et al.  A microRNA array reveals extensive regulation of microRNAs during brain development. , 2003, RNA.

[90]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[91]  Kenneth S Kosik,et al.  Neuronal RNA Granules A Link between RNA Localization and Stimulation-Dependent Translation , 2001, Neuron.

[92]  J. Haines,et al.  Complete genomic screen in Parkinson disease: evidence for multiple genes. , 2001, JAMA.

[93]  J. Joyce,et al.  Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[94]  F. Hartl,et al.  Hip, a novel cochaperone involved in the eukaryotic hsc70/hsp40 reaction cycle , 1995, Cell.

[95]  M. Borg,et al.  [Dopamine dysregulation syndrome in Parkinson's disease]. , 2008, Revue neurologique.

[96]  R. Barker,et al.  Neurotrophic factors as a therapeutic target for Parkinson's disease. , 2008, Expert opinion on therapeutic targets.

[97]  M. Farrer,et al.  The ups and downs of alpha-synuclein mRNA expression. , 2007, Movement disorders : official journal of the Movement Disorder Society.

[98]  T. Kaufman,et al.  Protein expression in a Drosophila model of Parkinson's disease. , 2007, Journal of proteome research.

[99]  S. Cohen,et al.  microRNA functions. , 2007, Annual review of cell and developmental biology.

[100]  H. Clevers Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[101]  H. Braak,et al.  Pathology associated with sporadic Parkinson's disease--where does it end? , 2006, Journal of neural transmission. Supplementum.

[102]  J. Andersen,et al.  Dopaminergic neurons. , 2005, The international journal of biochemistry & cell biology.

[103]  Janette K Burgess,et al.  Analysis of gene expression. , 2002, Methods in enzymology.

[104]  C. Colosimo,et al.  Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease , 2001, Journal of Neural Transmission.

[105]  H. Ichinose,et al.  Changes in cytokines and neurotrophins in Parkinson's disease. , 2000, Journal of neural transmission. Supplementum.